NDC 0069-1011-01 - Panzyga
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-1011
- Requested NDC
- 0069-1011-01
- Package NDCs from labels
- 0069-1011-01, 0069-1011-02
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Effective date
- 2025-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Panzyga - Pfizer Laboratories Div Pfizer Inc | Pfizer Laboratories Div Pfizer Inc | 2025-05-08 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-1011-01 | Panzyga | 10 mL in 1 BOTTLE, GLASS | SOLUTION | 10 | 10 | |
| 0069-1011-02 | Panzyga | 1 in 1 CARTON | SOLUTION | 1 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-1011-01 | ML - Milliliter | 0069-1011 | 292b7a59-4f74-49d4-a63a-a3030142a74b | 1 | 2019-09-05 |
| 0069-1011-02 | ML - Milliliter | 0069-1011 | 5c847fa5-1037-41d2-8cf2-d714ed1df345 | 1 | 2019-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ASCENIV | HUMAN IMMUNOGLOBULIN G | ADMA Biologics, Inc. | d74f4360-3b51-496c-96fb-84c3976958d2 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| QIVIGY kthm | HUMAN IMMUNOGLOBULIN G | Kedrion S.p.A. | 6f1933e0-240f-48f4-b246-8a30e63a4160 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| BIVIGAM | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | ADMA Biologics, Inc. | a2244aa0-a6d0-11df-b385-0002a5d5c51b | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.